COMMUNIQUÉS West-GlobeNewswire

Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

30/04/2025 - 06:15

Singapore , April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) , today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider [...]

Idorsia announces financial results for the first quarter 2025 – QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value of this outstanding asset

30/04/2025 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 30, 2025 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2025. Business highlights Q1 2025 QUVIVIQ™ ( [...]

Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed

30/04/2025 - 07:00

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million up by 3% in constant currencies (cc); stable in USD up by 5%[1] at a comparable growth rate ( [...]

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

30/04/2025 - 07:00

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 30, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]

Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO

30/04/2025 - 07:00

Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO New recruits expand senior team capabilities as the business progresses its lead HDAC6 inhibitor program, AGT [...]

CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings

30/04/2025 - 07:00

Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgo’s administration outside of clinical settings, for example at home 1-4 Phesgo label expansion [...]

Nicox : Résultats financiers de l’année 2024

30/04/2025 - 07:30

Communiqué de presse Nicox : Résultats financiers de l’année 2024 Chiffre d’affaires de Nicox SA de 7,9 millions d’euros pour l’année 2024 Produits exceptionnels de 13,7 millions d’euros suite à la cession du flux futur [...]

Nicox Provides Full Year 2024 Financial Results

30/04/2025 - 07:30

Press Release Nicox Provides Full Year 2024 Financial Results Nicox SA revenue of €7.9 million for full year 2024 Exceptional income of €13.7 million following the transfer of VYZULTA’s future revenue stream to Soleus [...]

Présentation des résultats d’une collaboration de recherche en Immuno-Oncologie avec le Centre Léon Bérard - Au congrès annuel de l’AACR 2025

30/04/2025 - 07:30

Présentation des résultats d’une collaboration de recherche en Immuno-Oncologie avec le Centre Léon Bérard Au congrès annuel de l’AACR 2025 Une nouvelle signature d’expression génique pour prédire la réponse clinique [...]

Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025

30/04/2025 - 07:30

Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025 New gene expression signature for cancer patients to predict clinical response to immune [...]

Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast

30/04/2025 - 08:00

L’ensemble des résultats des parties d’escalade et d’expansion de dose de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) après chimiothérapie d’induction chez des patients atteints d’un cancer du pancréas localement [...]

Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call

30/04/2025 - 08:00

Full results from the completed dose escalation part and dose expansion parts of a Phase 1 study evaluating JNJ-1900 (NBTXR3) after induction chemotherapy for patients with locally advanced or borderline resectable [...]

Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation

30/04/2025 - 08:00

Oslo, Norway, 30 April 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, invites to a webcast presentation of [...]

RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®

30/04/2025 - 09:00

BERN, Switzerland and MADRID, April 30, 2025 (GLOBE NEWSWIRE) -- RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA ® , their co-developed innovative AI algorithm for [...]

Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director

30/04/2025 - 09:00

Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director Egham, UK – 30 April 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company [...]

Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel

30/04/2025 - 04:00

VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)- [...]

Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025

30/04/2025 - 02:53

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the [...]

Mitolyn Reviews Consumer Reports 2025 - Mitolyn Reviews And Complaints - Mitolyn Weight Loss Supplement - What Is Mitolyn - Does Mitolyn Work - Is Mitolyn Legit or Scam!

29/04/2025 - 20:06

Tallmadge, OH, April 29, 2025 (GLOBE NEWSWIRE) -- (When people look for weight loss supplements, their experiences and real results matter more than advertisements. Mitolyn is gaining attention, and many are asking: [...]

Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024

29/04/2025 - 21:00

MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Paris, le 29 avril 2025 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, annonce [...]